Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Abstract:

With two vaccines approved but challenging logistics and a patchy supply chain slowing down the government's vaccination efforts, it is easy to understand this article's practical thinking!